Company Description
Hangzhou Lead Biotech Co., Ltd was established in October 23,2014. Our company is mainly engaged in custom synthesis especially for complex pharmaceutical intermediates and APIs. Our R&D team is led by a senior post doctor who was graduated from Purdue University and ever worked as project director in of Li Ka-shing's Hutchison Whampoa(Shanghai)Medicine. He ever participated in synthesis the most complex anti-tumor compound(Trabectedin , 48 steps in total) in the world when he worked as director in process and R&D department. The project is in the leading position of the world and at the stage of register and declaration currently.We have two R&D centers and the total area is 2000 square meters. We have 35 important R&D staffs and 3 cooperative plants.We are specialized in pharmaceutical intermediates and APIs and we can provide gram small pilot to commercial quantity.Representative products: Lusutrombopag(CAS:1110766-97-6), Bilastine, Retapamulin, Netupitant, Enzalutamide, etc